Related Articles
Top Stories
May 25 2012 13:58
The costs of the first phase of the Gauteng Freeway Improvement Project have increased significantly to almost R90bn, according to a report.
May 25 2012 19:13
Uncertainty over the future of the euro zone returned to push the rand down against the dollar.
May 25 2012 17:09
Clients hoping to cash in their end of month paychecks at Absa received a nasty surprise after the online banking system fell over.
Johannesburg - Litha Healthcare Group [JSE:LHG], a JSE-listed company with operations in the pharmaceutical, medical devices and biotechnology sectors of the healthcare industry, on Wednesday said it had signed a deal with Cpoint Capital, a Canadian-based firm.
It is headed by Ian Jacobson.
"This agreement represents an exciting and significant step forward for the Litha Group and in particular our Litha pharma division," said group CEO Selwyn Kahanovitz.
Litha Healthcare Group's footprint includes pharmaceutical products, vaccines and medical devices. The tie-up is expected to help grow its pharmaceutical division.
Jacobson will join Litha Healthcare Group's board of directors as a non-executive member.